Search Results 1521-1530 of 14766 for anti-TNF drugs

  1. Study of AZD0466 Monotherapy or in Combination in Patients With Advanced Haematological Malignancies - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo ... anti infection treatment within 14 days before first dose of study treatment ...

  2. Cancer Clinical Trials - Medical Professionals

    Drugs & Supplements · Healthy Lifestyle · Books ... anti-neutrophil cytoplasmic antibody (ANCA) ... Drugs used in chemotherapy, such as cisplatin ...

  3. Folate Receptor Alpha Peptide Vaccine With GM-CSF Versus GM-CSF Alone in Patients With Platinum Sensitive Ovarian Cancer - Mayo Clinic

    Receipt of the last dose of anti-cancer therapy (chemotherapy, immunotherapy, targeted therapy, biological/cell therapy, tumor embolization, monoclonal ...

  4. A Study to Evaluate the Safety and Effectiveness of OMS721 in Patients with Immunoglobulin A (IgA) Nephropathy - Mayo Clinic

    The study will assess proteinuria by 24-hour urine protein excretion (UPE) in g/day at 36 weeks from beginning of treatment. Participation eligibility.

  5. A Study to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors - Mayo Clinic

    About this study. To evaluate the effectiveness of NY-ESO-1-Specific (c259) T Cells, alone or in combination with other anti-cancer agents, in HLA-A*02:01, ...

  6. Sulfadiazine (Oral Route) Proper Use - Mayo Clinic

    For treatment of infections: Adults—2000 to 4000 milligrams (mg) per day, divided and given in 3 to 6 doses per day. Children and infants 2 ...

  7. Emtricitabine (Oral Route) Precautions - Mayo Clinic

    These are more common if you are female, very overweight (obese), or have been taking anti-HIV medicines for a long time. Call your doctor right away if you ...

  8. Depression and anxiety: Can I have both? - Mayo Clinic

    Symptoms of both conditions usually improve with psychological counseling (psychotherapy), medications, such as antidepressants, or both. Lifestyle changes, ...

  9. The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis (ExTINGUISH) - Mayo Clinic

    There are currently no medicinal products approved for the treatment of anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis, a rare disease. NMDAR ...

  10. A Study of Idasanutlin in Combination With Obinutuzumab in Relapsed/Refractory (R/R) Follicular Lymphoma (FL) and in Combination With Rituximab in R/R Diffuse Large B-Cell Lymphoma (DLBCL) Participants - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name. Search ... anti-CD20 monoclonal antibody (mAb) and for which ...